<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83873">
  <stage>Registered</stage>
  <submitdate>30/04/2009</submitdate>
  <approvaldate>25/05/2009</approvaldate>
  <actrnumber>ACTRN12609000342213</actrnumber>
  <trial_identification>
    <studytitle>The effect of pretreatment with a loading dose of intracoronary adenosine on periprocedural myonecrosis in patients undergoing percutaneous coronary intervention in the setting of non ST segment elevation acute coronary syndrome</studytitle>
    <scientifictitle>The effect of pretreatment with a loading dose of intracoronary adenosine on periprocedural myonecrosis in patients having percutaneous coronary intervention in the setting of non ST segment elevation acute coronary syndrome.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Non ST elevation acute coronary syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular</conditioncode1>
      <conditioncode2>Coronary heart disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intracoronary adenosine, 4mg (ADENOCOR)made up with 4mls of normal saline, as a single bolus dose.</interventions>
    <comparator>Normal saline , 4mls, given intracoronary as a single bolus</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Periprocedural myocardial injury characterised by troponin and myocardial Creatine Kinase (CKMB) rise.</outcome>
      <timepoint>8 and 24 hrs after percutaneous coronary intervention (PCI)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Angiographic outcomes - Thrombolysis in myocardial infarction (TIMI) flow grade, Myocardial blush grade</outcome>
      <timepoint>At the end of PCI</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients presenting with non ST segment elevation acute coronary syndrome (NSTEACS)</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>ST segment elevation myocardial infarction (STEMI), Cardiogenic Shock, bradycardia or Atrioventricular (AV) block, refractory ventricular arrhythmias, severe asthma, allergy to adenosine, totally occluded arteries resulting in TIMI grade 0 antegrade flow, pregnancy, unconscious or not for resuscitation,</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Patients fulfilling inclusion criteria are provided with trial information sheet and consented in an informed fashion. 

Those who require follow on percutaneous coronary intervention after their diagnostic angiogram are recruited into the trial.

Eligible pateints are randomised to recieve intracoronary adenosine (4mg adenosine made up with 4mls of normal saline) or placebo (4mls of normal saline). 

Allocation is held in sealed envelopes which are opened after the decision to recruit the patient immediately prior to angioplasty.</concealment>
    <sequence>The allocation sequence is computer generated (www.randomisation.com) and is performed by a nurse not involved in the trial. He has no role in determining eligibility and entry of patients, enrolling or consenting them in to the trial, nor with administering treatment or assessing outcome.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>1/10/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>144</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Monash Medical Center</primarysponsorname>
    <primarysponsoraddress>246 Clayton Road
Clayton 3168 VIC</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Monash Heart</fundingname>
      <fundingaddress>246 Clayton Road
Clayton 3168 VIC</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Monash cardiovascular research centre</fundingname>
      <fundingaddress>246 Clayton Road
Clayton 3168 VIC</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Monash cardiovascular research</sponsorname>
      <sponsoraddress>246 Clayton Road
Clayton 3168</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Prince of Wales Hospital</othercollaboratorname>
      <othercollaboratoraddress>Barker St Randwick 2031 NSW</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Adenosine has never been studied in coronary angioplasty in the setting of non ST segment elevation acute coronary syndrome. With promising observations of the benefits of adenosine in both elective and primary angioplasty settings, we hypothesise that intracoronary adenosine may prevent myocyte death (periprocedural myonecrosis) in this groups of patients undergoing coronary angioplasty.

We hypothesise that pretreatment with a intracoronary bolus dose of adenosine before coronary angioplasty decreases the amount of periprocedural myonecrosis in patients with non ST segment elevation acute coronary syndrome</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Southern Health Research Directorate</ethicname>
      <ethicaddress>Level 4, Main Block
246 Clayton Road
Clayton 3168</ethicaddress>
      <ethicapprovaldate>1/04/2009</ethicapprovaldate>
      <hrec>09053B</hrec>
      <ethicsubmitdate />
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Brian Ko</name>
      <address>Monash Heart 
246 Clayton Road
Clayton 3168</address>
      <phone>+61 414013976</phone>
      <fax />
      <email>brian.ko@sesiahs.health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Brian Ko</name>
      <address>Monash Heart
246 Clayton Road
Clayton 3168</address>
      <phone>+61 414013976</phone>
      <fax />
      <email>brian.ko@sesiahs.health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Brian Ko</name>
      <address>Monash Heart
246 Clayton Road
Clayton 3168</address>
      <phone>+61 414013976</phone>
      <fax />
      <email>brian.ko@sesiahs.health.nsw.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>